Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Biomarker robustness reveals the PDGF network as driving disease outcome in ovarian cancer patients in multiple studies

1 Jan 2012

Abstract excerpt

BACKGROUND: Ovarian cancer causes more deaths than any other gynecological cancer. Identifying the molecular mechanisms that drive disease progress in ovarian cancer is a critical step in providing therapeutics, improving diagnostics, and affiliating clinical behavior with disease etiology. Identification of molecular interactions that stratify prognosis is key in facilitating a clinical-molecular perspective....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bioinformatics and Genomic Networks
Share to Ferroptosis and cancer prognosis
Share to FOXO transcription factor regulation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 22236809
DOI: 10.1186/1752-0509-6-3

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Biomarker robustness reveals the PDGF network as driving disease outcome in ovarian cancer patients in multiple studiesPMID 22236809Read ↗

Deciphering Spatially Resolved Pathway Heterogeneity in Ovarian Cancer Post-Neoadjuvant ChemotherapySemantic proximity Read ↗

Geometric Network Analysis Provides Prognostic Information in Patients with High Grade Serous Carcinoma of the Ovary Treated with Immune Checkpoint InhibitorsSemantic proximity Read ↗

Geometric network analysis provides prognostic information in patients with high grade serous carcinoma of the ovary treated with immune checkpoint inhibitorsSemantic proximity Read ↗

Subnetwork-based prognostic biomarkers exhibit performance and robustness superior to gene-based biomarkers in breast cancerSemantic proximity Read ↗

Pathway-based classification of cancer subtypesSemantic proximity Read ↗

Physical cell-cell interactions regulate transcriptional programmes that control the responses of high grade serous ovarian cancer patients to therapySemantic proximity Read ↗

Integrative Network Analysis Reveals a MicroRNA-Based Signature for Prognosis Prediction of Epithelial Ovarian CancerSemantic proximity Read ↗

A network analysis to identify mediators of germline-driven differences in breast cancer prognosis.Semantic proximity Read ↗

Differential co-expression analysis reveals a novel prognostic gene module in ovarian cancer.Semantic proximity Read ↗

Gene signatures derived from transcriptomic-causal networks stratified colorectal cancer patients for effective targeted therapySemantic proximity Read ↗

Pan-cancer analysis of pathway-based gene expression pattern at the individual level reveals biomarkers of clinical prognosisSemantic proximity Read ↗

Phenotype-driven transitions in regulatory network structureSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.